Daily as of 3 Nov 16:00 ET
- Price
- below both $29.04 vs 50 $33.95 / 200 $32.07
- Projection
- 💀Death cross projected in 8 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 3 Nov 2025 · projected 29 bars out
IMVT | ImmunovantNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$29.04
+$0.63 (+2.22%)
Immunovant (IMVT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Nov 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $29.17 vs 50 $30.81 / 200 $26.00
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 15 Jun 2026 · projected 27 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $29.20 vs 50 $29.87 / 200 $36.69
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 2 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| week of 15 Jun 2026 | 🟨Golden moderate | weekly | 27 bars out | Not tested |
| 24 Apr 2026 | 🟨Golden | 4-hour | 30 bars out | 2 bar cross test |
| 2 Apr 2026 | 💀Death | 4-hour | 28 bars out | 4 bar cross test |
| 3 Nov 2025 | 🟨Golden steep | daily | 29 bars out | Not tested |
About IMVT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$44.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid